Kalpataru Projects Can Rally 25% On Industry Tailwinds, 'Buy' The Stock Says Motilal Oswal

Motilal Oswal expects growth for Kalpataru Projects to be driven by a healthy prospect pipeline, an improvement in execution, a stable-to-improving margin trajectory, and comfortable leverage

Kalpataru Projects has been witnessing improved order inflows across T&D from both domestic and international geographies since FY23.

Kalpataru Projects has a strong order book of Rs 606 billion spread across domestic and international geographies, providing healthy revenue visibility of 2.5-three years.

NDTV Profit’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer NDTV Profit’s subscribers an opportunity to expand their understanding of companies, sectors and the economy.

Motilal Oswal Report

We continue to remain positive on Kalpataru Projects International Ltd. based on its positioning across fast-growing power transmission and distribution- engineering, procurement and construction as well as the buildings and factories segment.

The company has a strong order book of Rs 606 billion spread across domestic and international geographies, providing healthy revenue visibility of 2.5-three years.

Following a weak execution in H1 FY25, a ramp-up is expected in the coming quarters, driven by the strong order book and easing payment situation. Benign commodity prices provide comfort on margin expansion, and interest expenses are likely to come down post the recent fund raise via QIP.

Promoter pledge has already come down to around 8% of the total shareholding, and with the expected IPO of real estate arm, we expect this to gradually wane down further. We slightly revise our estimates downward and roll forward our target price to Mar’27 estimates. Reiterate Buy on Kalpataru Projects with an SoTP-based target price of Rs 1,500, valuing core business at 19 times on two-year forward earnings.

Click on the attachment to read the full report:

Motilal Oswal Kalpataru Update.pdf
Read Document

Also Read: Biocon Gets Motilal Oswal's 'Buy' Upgrade On U.S. FDA Clearance For Malaysian Site

DISCLAIMER

This report is authored by an external party. NDTV Profit does not vouch for the accuracy of its contents nor is responsible for them in any way. The contents of this section do not constitute investment advice. For that you must always consult an expert based on your individual needs. The views expressed in the report are that of the author entity and do not represent the views of NDTV Profit.

Users have no license to copy, modify, or distribute the content without permission of the Original Owner.

lock-gif
To continue reading this story You must be an existing Premium User
Watch LIVE TV, Get Stock Market Updates, Top Business, IPO and Latest News on NDTV Profit. Feel free to Add NDTV Profit as trusted source on Google.
GET REGULAR UPDATES
Add us to your Preferences
Set as your preferred source on Google